We would like to make comment on the above article, which as its main conclusion found that abnormal p53 was associated with failure of response to radiotherapy in patients with rectal cancer. Our department has recently conducted a similar analysis focusing purely on rectal cancer undergoing neoadjuvant treatment and the conclusions that we drew were somewhat different.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: